These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22168424)

  • 1. The influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding.
    Mathis D; Benoist C
    Immunol Rev; 2012 Jan; 245(1):239-49. PubMed ID: 22168424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 diabetes: role of intestinal microbiome in humans and mice.
    Boerner BP; Sarvetnick NE
    Ann N Y Acad Sci; 2011 Dec; 1243():103-18. PubMed ID: 22211896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Models and approaches to dissect host-symbiont specificity.
    Mandel MJ
    Trends Microbiol; 2010 Nov; 18(11):504-11. PubMed ID: 20729086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospects for systems biology and modeling of the gut microbiome.
    Karlsson FH; Nookaew I; Petranovic D; Nielsen J
    Trends Biotechnol; 2011 Jun; 29(6):251-8. PubMed ID: 21392838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intestinal microbiome: relationship to type 1 diabetes.
    Neu J; Lorca G; Kingma SD; Triplett EW
    Endocrinol Metab Clin North Am; 2010 Sep; 39(3):563-71. PubMed ID: 20723820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of commensal microbiota on immune cell subsets and inflammatory responses.
    Chinen T; Rudensky AY
    Immunol Rev; 2012 Jan; 245(1):45-55. PubMed ID: 22168413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease.
    Atkinson MA; Chervonsky A
    Diabetologia; 2012 Nov; 55(11):2868-77. PubMed ID: 22875196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topographical variation in murine intestinal metabolic profiles in relation to microbiome speciation and functional ecological activity.
    Martin FP; Wang Y; Yap IK; Sprenger N; Lindon JC; Rezzi S; Kochhar S; Holmes E; Nicholson JK
    J Proteome Res; 2009 Jul; 8(7):3464-74. PubMed ID: 19492798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The intestinal microbiota and inflammatory bowel disease].
    Guarner F
    Gastroenterol Hepatol; 2011 Mar; 34(3):147-54. PubMed ID: 21377761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cultivation of epithelial-associated microbiota by the immune system.
    Thomas AD; Parker W
    Future Microbiol; 2010 Oct; 5(10):1483-92. PubMed ID: 21073309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thymus-dependent immune system in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. Animal model and human studies.
    Buschard K
    Dan Med Bull; 1985 Jun; 32(3):139-51. PubMed ID: 3160550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spontaneous animal models for insulin-dependent diabetes (type 1 diabetes)].
    Saï P; Gouin E
    Vet Res; 1997; 28(3):223-9. PubMed ID: 9273084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory properties of the intestinal microbiome effecting the development and treatment of diabetes.
    Romano-Keeler J; Weitkamp JH; Moore DJ
    Curr Opin Endocrinol Diabetes Obes; 2012 Apr; 19(2):73-80. PubMed ID: 22357099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the ties between celiac disease and intestinal microbiota.
    Sanz Y; De Pama G; Laparra M
    Int Rev Immunol; 2011 Aug; 30(4):207-18. PubMed ID: 21787226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive review of interventions in the NOD mouse and implications for translation.
    Shoda LK; Young DL; Ramanujan S; Whiting CC; Atkinson MA; Bluestone JA; Eisenbarth GS; Mathis D; Rossini AA; Campbell SE; Kahn R; Kreuwel HT
    Immunity; 2005 Aug; 23(2):115-26. PubMed ID: 16111631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno- and genetic therapy in autoimmune diseases.
    Chernajovsky Y; Dreja H; Daly G; Annenkov A; Gould D; Adams G; Croxford JL; Baker D; Podhajcer OL; Mageed RA
    Genes Immun; 2000 Jun; 1(5):295-307. PubMed ID: 11196690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can progression of IDDM be prevented in newly diagnosed patients by BCG immunotherapy?
    Singh B; Elliot JF
    Diabetes Metab Rev; 1997 Dec; 13(4):320-1. PubMed ID: 9509286
    [No Abstract]   [Full Text] [Related]  

  • 19. The developing intestinal microbiome and its relationship to health and disease in the neonate.
    Murgas Torrazza R; Neu J
    J Perinatol; 2011 Apr; 31 Suppl 1():S29-34. PubMed ID: 21448201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and prevention of type 1 diabetes mellitus by viruses.
    Yoon JW
    Diabete Metab; 1992; 18(5):378-86. PubMed ID: 1292946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.